Jill Broadfoot
Chief Financial Officer (CFO)
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | aTYR PHARMA INC (ATYR) | Chief Financial Officer | $471,790 | $1,309,913 |
| 2024 | aTYR PHARMA INC (ATYR) | Chief Financial Officer | $428,899 | $746,163 |
| 2023 | aTYR PHARMA INC (ATYR) | Chief Financial Officer | $414,395 | $677,837 |
| 2022 | aTYR PHARMA INC (ATYR) | Chief Financial Officer | $414,395 | $913,493 |
| 2021 | aTYR PHARMA INC (ATYR) | Chief Financial Officer | $376,723 | $917,443 |
| 2020 | aTYR PHARMA INC (ATYR) | Chief Financial Officer | $365,750 | $698,780 |
| 2019 | aTYR PHARMA INC (ATYR) | Chief Financial Officer | $350,000 | $454,624 |
| 2018 | aTYR PHARMA INC (ATYR) | Chief Financial Officer | $148,526 | $334,123 |
Earnings-call appearances
-
aTyr Pharma Conference Call2025-09-15
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q4 FY2024 Earnings Call2025-03-13
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q4 FY2023 Earnings Call2024-03-14
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q4 FY2022 Earnings Call2023-03-09
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q3 FY2022 Earnings Call2022-11-10
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q2 FY2022 Earnings Call2022-08-15
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q1 FY2022 Earnings Call2022-04-13
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q4 FY2021 Earnings Call2022-03-14
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q3 FY2021 Earnings Call2021-09-30
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q2 FY2021 Earnings Call2021-06-30
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q1 FY2021 Earnings Call2021-05-13
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q4 FY2020 Earnings Call2021-03-23
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q3 FY2020 Earnings Call2020-11-12
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q2 FY2020 Earnings Call2020-08-13
aTYR PHARMA INC (ATYR)
-
aTYR PHARMA INC Q1 FY2020 Earnings Call2020-05-12
aTYR PHARMA INC (ATYR)